1. Home
  2. IART vs VSTM Comparison

IART vs VSTM Comparison

Compare IART & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

SELL

Current Price

$14.10

Market Cap

951.9M

Sector

Health Care

ML Signal

SELL

Logo Verastem Inc.

VSTM

Verastem Inc.

SELL

Current Price

$7.78

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IART
VSTM
Founded
1989
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
951.9M
1.1B
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
IART
VSTM
Price
$14.10
$7.78
Analyst Decision
Hold
Strong Buy
Analyst Count
12
10
Target Price
$15.67
★ $17.22
AVG Volume (30 Days)
1.1M
★ 3.1M
Earning Date
10-21-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 17.49
EPS
★ 0.19
N/A
Revenue
N/A
★ $30,914,000.00
Revenue This Year
$0.55
$248.46
Revenue Next Year
$1.86
$34.25
P/E Ratio
$73.58
★ N/A
Revenue Growth
N/A
★ 209.14
52 Week Low
$8.70
$3.43
52 Week High
$20.49
$10.82

Technical Indicators

Market Signals
Indicator
IART
VSTM
Relative Strength Index (RSI) 51.45 38.00
Support Level $11.96 $7.72
Resistance Level $14.28 $7.86
Average True Range (ATR) 0.78 0.56
MACD 0.20 -0.24
Stochastic Oscillator 64.61 3.16

Price Performance

Historical Comparison
IART
VSTM

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: